We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » JUDGE DENIES REQUEST FOR ACTION IN LEVOTHYROXINE SUIT
JUDGE DENIES REQUEST FOR ACTION IN LEVOTHYROXINE SUIT
July 16, 2004
A District of Columbia federal court has refused King Pharmaceuticals’ request to revoke FDA approval of supplemental new drug applications (sNDAs) that propose to establish bioequivalence between King’s thyroid product Levoxyl and two other products: Jerome Stevens’ Unithroid and Mova Pharmaceutical’s Levo-T.